RecruitingNot ApplicableNCT04109846

Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos

Transfer of Aneuploid or Mosaic Embryos Following Preimplantation Genetic Testing


Sponsor

Stanford University

Enrollment

300 participants

Start Date

Apr 11, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Euploid Transfer and Non-euploid embryo transfer for people with aneuploidy, mosaicism, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-euploid embryo transfer

Other than choice of embryo for transfer, all other medical interventions will be standard of care protocols

OTHEREuploid Transfer

Standard of Care Protocol


Locations(1)

Stanford Fertility and Reproductive Medicine Center

Sunnyvale, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04109846


Related Trials